Abstract
B cells have recently been appreciated as paracrine mediators of solid tumor development. Their ability to influence various hallmarks of cancer development, aside from antigen presentation, can be attributed to the diversity of soluble mediators they express, including cytokines and immunoglobulins, that can act directly and indirectly on the diversity of leukocyte subsets that infiltrate developing tumors, evolving neoplastic cells, as well as select T cell populations in secondary lymphoid organs and within tumor stroma. Herein, we review the literature supporting these interactions and discuss novel approaches to ameliorate protumoral B cell effects for anti-cancer therapy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1644-1649 |
| Number of pages | 6 |
| Journal | Experimental Cell Research |
| Volume | 319 |
| Issue number | 11 |
| DOIs | |
| State | Published - Jul 1 2013 |
Funding
The authors thank members of the Coussens laboratory for critical discussions on content. AJG is supported by T32I078903-04 . LMC acknowledges support from the NIH/NCI, a DOD BCRP Era of Hope Scholar Expansion Award, Susan B Komen Foundation, and the Breast Cancer Research Foundation.
| Funders | Funder number |
|---|---|
| Susan B. Komen Foundation | |
| Author National Institutes of Health National Institutes of Health National Institutes of Health National Institutes of Health The Bev Hartig Huntington's Disease Foundation National Institutes of Health | |
| U.S. Department of Defense | |
| National Institute of Health-National Cancer Institute | R01CA130980 |
| Breast Cancer Research Foundation |
Keywords
- B cells
- Cancer
- Inflammation
- Leukocytes
- Myeloid cells
ASJC Scopus subject areas
- Cell Biology
Fingerprint
Dive into the research topics of 'B cells and their mediators as targets for therapy in solid tumors'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS